focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,783.50
Bid: 1,780.00
Ask: 1,780.50
Change: -29.00 (-1.60%)
Spread: 0.50 (0.028%)
Open: 1,792.50
High: 1,802.00
Low: 1,775.50
Prev. Close: 1,812.50
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

London midday: Stocks dip despite barrage of positive readings on the economy

Fri, 23rd Apr 2021 12:04

(Sharecast News) - Stocks are holding lower at the end of the week despite very positive news out on the UK economy, after Bloomberg reported that Democrats on Capitol Hill want to double the US capital gains tax to nearly 39.6%.
"European markets are on the back foot in early trade, with valuations taking a dive in the wake of Joe Biden's proposal to implement a near 50% stamp duty rate on high earners. With the past year having seen traders react with glee over repeated bouts of stimulus, traders are gradually seeing the uncomfortable truth that those debts have to be paid one way or another," said Josh Mahony, senior market analyst at IG.

"Quite whether Biden manages to garner enough support to pass this bill remains to be seen, with the president likely to require almost unanimous support from the Democrats given the expected widespread rejection from the GOP."

Another key consideration according to experts was whether any tax hikes would be applied retroactively to 2021.

Against that backdrop, as of 1205 BST the FTSE 100 was trading lower by 0.48% or 33.12 points to 6,905.04, while the second-tier index was down by 0.22% or 49.39 points at 22,315.48.

Futures tracking the S&P 500 on the other hand were now bouncing back by 11.5 points to 4,139.25.

Sterling was higher alongside too, adding 0.33% to 1.3885.

Barrage of positive economic data

The news on the economic front nevertheless was surprisingly positive.

According to the Office for National Statistics, UK retail sales surged at a month-on-month pace of 5.4% in March (consensus: 1.5%).

That was despite non-essential stores having remained shut until 12 April.

IHS Markit's Purchasing Managers Indices for factory and services also came in ahead of forecasts for April, with record levels of optimism for the year ahead "setting the scene for a bumper second quarter for the economy".

Consultancy GfK meanwhile reported an improvement in its UK consumer confidence index from -16 for March to -15 in April, although shoppers appeared to be returning "quite tentatively" to stores, said Samuel Tombs at Pantheon Macroeconomics.

Public sector net borrowing data for March also came in better than expected, at £28.0bn (consensus: £22.0bn), for total 2020/21 fiscal year borrowing £303.1bn or 14.5% of GDP, the most since WWII, but in any case than the OBR's projection for £354.6bn in the March budget.

First Group sells US assets to lower debt pile

FirstGroup has agreed to sell its First Student and First Transit US bus businesses to EQT Infrastructure for an enterprise value of £3.3bn. The UK transport group said it would use £2.19bn of initial net proceeds to cut debt, pay into its pension schemes and return £365m, or 30p a share, to shareholders during 2021.

GlaxoSmithKline said the US Food and Drug Administration (FDA) has approved 'Jemperli', or dostarlimab-gxly, based on its Biologics License Application. The AIM-traded firm said dostarlimab, a programmed death receptor-1 (PD-1) blocking antibody, is indicated for the treatment of adult patients with mismatch repair-deficient recurrent or advanced endometrial cancer, as determined by an FDA-approved test, that have progressed on or following prior treatment with a platinum-containing regimen. It said the indication was given accelerated approval based on tumour response rate and durability of response.

LondonMetric Property has sold two long income assets let to Marks & Spencer and Wickes in Derby for a combined £11.1m to unnamed buyers. The sale represents a blended net initial yield of 6% and a 7% surplus to the last reported book value. One property is a M&S Foodhall, sold by way of a forward commitment to an overseas private investor for £6.2m and the other a Wickes store, sold to an overseas property company for £4.9m.

Market Movers

FTSE 100 (UKX) 6,908.47 -0.43%
FTSE 250 (MCX) 22,309.18 -0.25%
techMARK (TASX) 4,346.48 -0.39%

FTSE 100 - Risers

Intertek Group (ITRK) 6,252.00p 1.86%
Taylor Wimpey (TW.) 187.55p 1.49%
Evraz (EVR) 639.40p 1.46%
Just Eat Takeaway.Com N.V. (CDI) (JET) 7,956.00p 1.26%
Glencore (GLEN) 295.90p 1.16%
Flutter Entertainment (CDI) (FLTR) 15,075.00p 1.14%
Smith (DS) (SMDS) 417.10p 0.97%
Anglo American (AAL) 3,119.50p 0.82%
InterContinental Hotels Group (IHG) 5,148.00p 0.82%
WPP (WPP) 960.00p 0.80%

FTSE 100 - Fallers

International Consolidated Airlines Group SA (CDI) (IAG) 196.08p -2.20%
Next (NXT) 7,880.00p -2.11%
Hargreaves Lansdown (HL.) 1,667.50p -1.74%
Diageo (DGE) 3,260.00p -1.70%
Hikma Pharmaceuticals (HIK) 2,396.00p -1.68%
Reckitt Benckiser Group (RKT) 6,691.00p -1.62%
Smith & Nephew (SN.) 1,470.00p -1.47%
United Utilities Group (UU.) 953.40p -1.47%
Sainsbury (J) (SBRY) 245.30p -1.37%
Auto Trader Group (AUTO) 569.00p -1.35%

FTSE 250 - Risers

FirstGroup (FGP) 92.55p 8.75%
SSP Group (SSPG) 337.90p 2.83%
Network International Holdings (NETW) 430.00p 2.38%
National Express Group (NEX) 324.00p 2.02%
Crest Nicholson Holdings (CRST) 415.80p 2.01%
Fidelity China Special Situations (FCSS) 438.00p 1.86%
Mitchells & Butlers (MAB) 310.80p 1.83%
Restaurant Group (RTN) 124.80p 1.79%
Vistry Group (VTY) 1,232.00p 1.73%
XP Power Ltd. (DI) (XPP) 5,230.00p 1.55%

FTSE 250 - Fallers

Workspace Group (WKP) 801.50p -4.13%
AO World (AO.) 285.80p -3.18%
AJ Bell (AJB) 437.00p -2.85%
Capita (CPI) 42.73p -2.67%
easyJet (EZJ) 984.80p -2.64%
Beazley (BEZ) 328.30p -2.55%
Carnival (CCL) 1,637.20p -2.28%
CMC Markets (CMCX) 491.00p -2.00%
IWG (IWG) 349.90p -1.85%
Allianz Technology Trust (ATT) 2,940.00p -1.84%
More News
26 Jan 2024 10:47

Citi hikes target price for GSK but stays 'neutral'

(Sharecast News) - Shares in biopharma giant GSK were rising on Friday, helped by forecast upgrades from Citi, which raised its target price on the stock from 1,535p to 1,700p.

Read more
24 Jan 2024 15:08

Private equity firm Yellow Wood close to deal to acquire ChapStick-sources

Jan 24 (Reuters) - Private equity firm Yellow Wood Partners is in advanced talks to acquire ChapStick, a lip balm brand, from Haleon Plc, the former consumer health division of drug developer GSK Plc, four people familiar with the matter said.

Read more
24 Jan 2024 14:34

UK earnings, trading statements calendar - next 7 days

Thursday 25 January 
Britvic PLCTrading Statement
Conduit Holdings LtdTrading Statement
CVS Group PLCTrading Statement
Dr Martens PLCTrading Statement
Fevertree Drinks PLCTrading Statement
Foxtons Group PLCFull Year Results
Fuller, Smith & Turner PLCTrading Statement
Halfords Group PLCTrading Statement
Idox PLCFull Year Results
IG Group Holdings PLCHalf Year Results
Intermediate Capital Group PLCTrading Statement
Mitie Group PLCTrading Statement
NCC Group PLCHalf Year Results
Newmark Security PLCHalf Year Results
Next 15 Group PLCTrading Statement
PPHE Hotel Group LtdTrading Statement
Secure Trust Bank PLCTrading Statement
St James's Place PLCTrading Statement
Time Finance PLCHalf Year Results
Titon Holdings PLCFull Year Results
Wizz Air Holdings PLCQ3 Results
Workspace Group PLCTrading Statement
Friday 26 January 
Paragon Banking Group PLCTrading Statement
Record PLCTrading Statement
Superdry PLCHalf Year Results
Taylor Maritime Investments LtdTrading Statement
WH Smith PLCTrading Statement
YouGov PLCTrading Statement
Monday 29 January 
Team Internet Group PLCTrading Statement
Tuesday 30 January 
Diaceutics PLCTrading Statement
Diageo PLCHalf Year Results
Kromek Group PLCHalf Year Results
Luceco PLCTrading Statement
Oxford Cannabinoid Technologies Holdings PLCHalf Year Results
Pets at Home Group PLCTrading Statement
Renewi PLCTrading Statement
Saga PLCTrading Statement
SSP Group PLCTrading Statement
SThree PLCFull Year Results
Synthomer PLCTrading Statement
Wednesday 31 January 
Aberforth Smaller Companies Trust PLCFull Year Results
abrdn Private Equity Opportunities Trust PLCFull Year Results
Ecora Resources PLCTrading Statement
GSK PLCFull Year Results
ITM Power PLCHalf Year Results
NWF Group PLCHalf Year Results
  
Comments and questions to newsroom@alliancenews.com
  
A full 21-day events calendar is provided each day with a subscription to Alliance News UK Professional.
  
Copyright 2024 Alliance News Ltd. All Rights Reserved.

Read more
22 Jan 2024 21:22

Fate of most remaining Zantac lawsuits weighed by Delaware judge

Jan 22 (Reuters) - GSK, Pfizer and other pharmaceutical companies are urging a judge in Delaware this week to find that evidence plaintiffs' lawyers want to use in about 72,000 lawsuits claiming that the discontinued heartburn drug Zantac caused cancer is not supported by science.

Read more
22 Jan 2024 17:08

Fate of most remaining Zantac lawsuits weighed by Delaware judge

Jan 22 (Reuters) - GSK, Pfizer and other pharmaceutical companies will urge a judge in Delaware this week to find that evidence plaintiffs' lawyers want to use in about 72,000 lawsuits claiming that the discontinued heartburn drug Zantac caused cancer is not supported by science.

Read more
22 Jan 2024 09:34

IN BRIEF: Oxford Nanopore appoints Keher to CFO as Cowper becomes COO

Oxford Nanopore Technologies - Oxford, England-based company specialising in nanopore DNA-sequencing - Appoints Nick Keher as chief financial officer and director, effective immediately. Keher will replace Tim Cowper as he moves into a new role as Oxford Nanopore's chief operating officer. The company says that Cowper has been performing the majority of COO duties for the past five years, and that he will lead the company's efforts to expand its international footprint. The company also says that new CFO Keher possesses "significant experience of financial leadership of complex, scientific businesses", having served in similar roles at Clinigen Group PLC, BenevolentAI SA, Royal Bank of Canada, Investec PLC and GSK PLC.

Read more
17 Jan 2024 09:38

UPDATE: GSK raises GBP978 million as cuts stake in Haleon to 4.2%

(Alliance News) - GSK PLC early Wednesday confirmed it agreed to sell 300 million shares in Haleon PLC, reducing its remaining stake in the consumer healthcare products spin-off to just 4.2%.

Read more
17 Jan 2024 08:05

GSK raises £978m through Haleon share sale

(Sharecast News) - GSK said on Wednesday that it has raised around £978m from the sale of shares in Haleon.

Read more
17 Jan 2024 07:46

LONDON BRIEFING: UK inflation surprises as unexpectedly rises to 4.0%

(Alliance News) - Stocks in London are called to open lower on Wednesday, following some hotter-than-expected consumer price data from the UK.

Read more
17 Jan 2024 07:31

GSK raises $1.24 bln from latest Haleon stake sale

Jan 17 (Reuters) - GSK has raised 978 million pounds ($1.24 billion) from a discounted sale of a stake in its spun-off consumer healthcare business Haleon, the British drugmaker said on Wednesday.

Read more
16 Jan 2024 17:04

GSK to sell GBP1 billion worth of Haleon shares as trims stake again

(Alliance News) - GSK PLC on Tuesday said it intends to sell around GBP1.00 billion worth of shares in Haleon PLC, as it continues to reduce its shareholding in the Weybridge, Surrey-based consumer healthcare spin-off.

Read more
16 Jan 2024 09:14

LONDON BROKER RATINGS: UBS raises GSK and cuts AstraZeneca

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning:

Read more
16 Jan 2024 08:15

UBS downgrades AstraZeneca to 'sell'

(Sharecast News) - UBS has downgraded AstraZeneca and upgraded rival GSK as part of its latest review of the European pharmaceutical sector.

Read more
16 Jan 2024 07:37

LONDON BRIEFING: UK jobless rate sticks at 4.2% but pay growth slows

(Alliance News) - Stocks in London are called to open lower on Tuesday, following data showing that the UK jobless rate was unchanged at 4.2% as pay growth slowed.

Read more
15 Jan 2024 08:42

Zantac fallout unfairly weighing on GSK, says Shore Capital

(Sharecast News) - Shore Capital has raised its target price and maintained a positive stance on biopharma giant GSK, saying that worries about the potential cost of Zantac litigation are unfairly weighing on the stock.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.